Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio helps it to produce steady revenue and profits.
Source: https://www.fool.com/investing/2026/01/19/best-healthcare-st…
Here is how Kaiser Aluminum (KALU) and Tenaris S.A. (TS) have performed compared to their sector so far this year.
Multiple headwinds in the homebuilding market have caused the stocks of D.R. Horton and Lennar to fall.
I’ll break down of three MLPs/energy partnerships using yield, distribution growth, cash-flow coverage, leverage, and cycle durability as the deciding factors. Contenders include contrasts between a scale-driven midstream operator with a data-center angle, a consistently executing pipeline partnership with repeated 12.5% hikes, and a royalty model built around zero capex and tax-advantaged payouts.
